An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...
In a recent study, talk therapy in Parkinson’s disease led to significant improvement in patients' well-being, ...
The glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease severity.
Magnetic Resonance-guided Focused Ultrasound tech has the potential to treat conditions like essential tremors & Parkinson’s, ...